Patents by Inventor Leila DARDAEI ALGHALANDIS

Leila DARDAEI ALGHALANDIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMBINATION COMPRISING AN ALK INHIBITOR AND A SHP2 INHIBITOR
    Publication number: 20220241277
    Abstract: A pharmaceutical combination comprising an ALK inhibitor, in free form or a pharmaceutically acceptable salt thereof, and a SHP2 inhibitor, in free form or a pharmaceutically acceptable salt thereof, and optionally a pharmaceutically acceptable carrier, for simultaneous or sequential administration; the uses of such combination in the treatment of proliferative diseases; and methods of treating a subject suffering from a proliferative disease comprising administering a therapeutically effective amount of such combination.
    Type: Application
    Filed: April 6, 2022
    Publication date: August 4, 2022
    Inventors: Leila DARDAEI ALGHALANDIS, Jeffrey Adam ENGELMAN, Huaixiang HAO, Matthew J. LAMARCHE, Fang LI, Hui-Qin WANG
  • PHARMACEUTICAL COMBINATION COMPRISING AN ALK INHIBITOR AND A SHP2 INHIBITOR
    Publication number: 20190343836
    Abstract: A pharmaceutical combination comprising an ALK inhibitor, in free form or a pharmaceutically acceptable salt thereof, and a SHP2 inhibitor, in free form or a pharmaceutically acceptable salt thereof, and optionally a pharmaceutically acceptable carrier, for simultaneous or sequential administration; the uses of such combination in the treatment of proliferative diseases; and methods of treating a subject suffering from a proliferative disease comprising administering a therapeutically effective amount of such combination.
    Type: Application
    Filed: January 8, 2018
    Publication date: November 14, 2019
    Inventors: Leila DARDAEI ALGHALANDIS, Jeffrey Adam ENGELMAN, Huaixiang HAO, Matthew J. LAMARCHE, Fang LI, Hui-Qin WANG